| Website | delphiventures.com |
| Phone | 650-854-9650 |
| Employees | |
| Founded | 1988 |
| Description | Venture capital Firm |
The partners at Delphi Ventures help build healthcare companies. We provide capital, contacts and leadership to help entrepreneurs realize their vision. Healthcare is our sole focus. Founded in 1988, Delphi was among the first venture capital firms in the United States to focus on early stage medical device and biotechnology investments.
| Company | Date | Round | Size | Participants |
| Karyopharm Therapeutics | 5/13 | Series B | $48.2M | 1 |
| Revance Therapeutics | 4/13 | Series E | $33M | 3 |
| PTC Therapeutics | 3/13 | Venture Round | $60M | 8 |
| Ivantis | 1/13 | Series B | $27M | 4 |
| Labcyte | 1/13 | Series D | $5.3M | 7 |
| PTC Therapeutics | 7/12 | Venture Round | $30M | 4 |
| Astute Medical | 6/12 | Series C | $40.4M | 6 |
| TriVascular | 6/12 | Series D | $60M | 7 |
| Alder Biopharmaceuticals | 4/12 | Series D | $38M | 7 |
| Sequent Medical | 3/12 | Series C | $26M | 4 |
| Pivot Medical | 11/11 | Series C | $32M | 4 |
| Sensors for Medicine and Science | 11/11 | Series D | $54.1M | 5 |
| AEGEA Medical | 6/11 | Series B | $13.3M | 3 |
| PolyRemedy | 6/11 | Series C | $20M | 4 |
| Cameron Health | 5/11 | Venture Round | $107M | 2 |
| PixelOptics | 4/11 | Venture Round | $45M | 4 |
| Astute Medical | 3/11 | Series B | $13M | 4 |
| ELENZA | 2/11 | Series B | $24M | 3 |
| Relypsa | 9/10 | Series B | $70M | 6 |
| NeuroVista | 8/10 | Venture Round | $16.5M | 4 |
| TriVascular | 8/10 | Series C | $60M | 5 |
| BARRX Medical | 7/10 | Series D | $15M | 6 |
| Calithera Biosciences | 7/10 | Series A | $40M | 5 |
| Anulex | 6/10 | Series E | $18.3M | 5 |
| Breathe Technologies | 5/10 | Series C | $23M | 4 |
| Astute Medical | 5/10 | Series B | $26.5M | 4 |
| PTC Therapeutics | 12/09 | Series E | $50M | 5 |
| TriVascular | 11/09 | Series B | $30M | 4 |
| Barosense | 8/09 | Series D | $27M | 7 |
| VytronUS | 6/09 | Series B | $11M | 2 |
| PhotoThera | 5/09 | Series D | $50M | 5 |
| Primaeva Medical | 2/09 | Series C | $6M | 3 |
| PixelOptics | 10/08 | Venture Round | $30M | 5 |
| EBR Systems | 6/08 | Series C | $35M | 5 |
| NovaSys | 5/08 | Venture Round | $49.5M | 10 |
| TriVascular2 | 3/08 | Series A | $65M | 4 |
| TriVascular | 3/08 | Series A | $65M | 4 |
| Breathe Technologies | 3/08 | Series B | $15M | 4 |
| Cameron Health | 3/08 | Series E | $14M | 4 |
| Aragon Surgical | 1/08 | Series B | $25M | 4 |
| Evalve | 11/07 | Series D | $60M | 5 |
| Relypsa | 10/07 | Series A | $33M | 6 |
| Vibrynt | 8/07 | Series A | $16M | 3 |
| VytronUS | 8/07 | Series A | $6.6M | 2 |
| Paracor Medical | 6/07 | Series D | $44M | 8 |
| NeuroVista | 5/07 | Series B | $33.8M | 5 |
| Reliant Technologies | 4/07 | Series E | $15M | 3 |
| Phenomix | 3/07 | Series C | $55M | 10 |
| Primaeva Medical | 12/06 | Series B | $7M | 2 |
| Anulex | 7/06 | Series C | $20M | 6 |
| KAI Pharmaceuticals | 5/06 | Series B | $35M | 7 |
| PhotoThera | 4/06 | Series C | $30.5M | 6 |
| Primaeva Medical | 2006 | Series A | $1.25M | 2 |
| PTC Therapeutics | 11/05 | Venture Round | $26.6M | 9 |
| Adiana | 8/05 | Series D | $23M | 9 |
